Just remember, this is the same stock that has delayed its application for COVID vaccine.
Novavax stock surged 14.2% in premarket trading
Biotechnology company Novavax stock surged 14.2% in premarket trading after filing for authorization
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
5
举报
登录后可参与评论
暂无评论